Targeted nanoprobes reveal early time point kinetics in vivo by time-resolved MRI.

Authors:
Bhirde A; Guo N; Chen X.

Journal:
Theranostics

Publication Year: 2011

PMCID:
PMC3092450

PMID:
21562633

View on PubMed View on PMC
Journal Information

Full Title: Theranostics

Abbreviation: Theranostics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
20-HETE mediated TRPV1 activation drives allokinesis via MrgprA3<sup>+</sup> neurons in chronic der…
Yu G; Liu P; Huang X and 11 more (2024) - Transparency Score: 3/6
Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpres…
Amer L; Retout M; Jokerst JV. (2024) - Transparency Score: 3/6
Annotation of CD8<sup>+</sup> T-cell function via ICAM-1 imaging identifies FAK inhibition as an ad…
Zhang T; Zhang Y; Zhao Y and 11 more (2024) - Transparency Score: 3/6
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-N…
Trautwein NF; Schwenck J; Seitz C and 12 more (2024) - Transparency Score: 3/6
Antibacterial micro/nanomotors: current research progress, challenges, and opportunities.
Liu XY; Li RF; Jia J and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest: The authors have declared that no conflict of interest exists."

Evidence found in paper:

"This work was supported by the intramural research program (IRP), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025